Request for Covid-19 Impact Assessment of this Report
The United States Flunixin Meglumine Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Flunixin Meglumine Injection market, reaching US$ million by the year 2028. As for the Europe Flunixin Meglumine Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Flunixin Meglumine Injection players cover Norbrook, Zoteis, Merck Animal Health, and Virbac Animal Health India Private Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Flunixin Meglumine Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
10ml/Dose
20ml/ Dose
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Animal muscle pain
Animal febrile disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flunixin Meglumine Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Flunixin Meglumine Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Flunixin Meglumine Injection by Country/Region, 2017, 2022 & 2028
2.2 Flunixin Meglumine Injection Segment by Type
2.2.1 10ml/Dose
2.2.2 20ml/ Dose
2.3 Flunixin Meglumine Injection Sales by Type
2.3.1 Global Flunixin Meglumine Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Flunixin Meglumine Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Flunixin Meglumine Injection Sale Price by Type (2017-2022)
2.4 Flunixin Meglumine Injection Segment by Application
2.4.1 Animal muscle pain
2.4.2 Animal febrile disease
2.4.3 Others
2.5 Flunixin Meglumine Injection Sales by Application
2.5.1 Global Flunixin Meglumine Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Flunixin Meglumine Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Flunixin Meglumine Injection Sale Price by Application (2017-2022)
3 Global Flunixin Meglumine Injection by Company
3.1 Global Flunixin Meglumine Injection Breakdown Data by Company
3.1.1 Global Flunixin Meglumine Injection Annual Sales by Company (2020-2022)
3.1.2 Global Flunixin Meglumine Injection Sales Market Share by Company (2020-2022)
3.2 Global Flunixin Meglumine Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Flunixin Meglumine Injection Revenue by Company (2020-2022)
3.2.2 Global Flunixin Meglumine Injection Revenue Market Share by Company (2020-2022)
3.3 Global Flunixin Meglumine Injection Sale Price by Company
3.4 Key Manufacturers Flunixin Meglumine Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Flunixin Meglumine Injection Product Location Distribution
3.4.2 Players Flunixin Meglumine Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Flunixin Meglumine Injection by Geographic Region
4.1 World Historic Flunixin Meglumine Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Flunixin Meglumine Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Flunixin Meglumine Injection Annual Revenue by Geographic Region
4.2 World Historic Flunixin Meglumine Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Flunixin Meglumine Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Flunixin Meglumine Injection Annual Revenue by Country/Region
4.3 Americas Flunixin Meglumine Injection Sales Growth
4.4 APAC Flunixin Meglumine Injection Sales Growth
4.5 Europe Flunixin Meglumine Injection Sales Growth
4.6 Middle East & Africa Flunixin Meglumine Injection Sales Growth
5 Americas
5.1 Americas Flunixin Meglumine Injection Sales by Country
5.1.1 Americas Flunixin Meglumine Injection Sales by Country (2017-2022)
5.1.2 Americas Flunixin Meglumine Injection Revenue by Country (2017-2022)
5.2 Americas Flunixin Meglumine Injection Sales by Type
5.3 Americas Flunixin Meglumine Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flunixin Meglumine Injection Sales by Region
6.1.1 APAC Flunixin Meglumine Injection Sales by Region (2017-2022)
6.1.2 APAC Flunixin Meglumine Injection Revenue by Region (2017-2022)
6.2 APAC Flunixin Meglumine Injection Sales by Type
6.3 APAC Flunixin Meglumine Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Flunixin Meglumine Injection by Country
7.1.1 Europe Flunixin Meglumine Injection Sales by Country (2017-2022)
7.1.2 Europe Flunixin Meglumine Injection Revenue by Country (2017-2022)
7.2 Europe Flunixin Meglumine Injection Sales by Type
7.3 Europe Flunixin Meglumine Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Flunixin Meglumine Injection by Country
8.1.1 Middle East & Africa Flunixin Meglumine Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Flunixin Meglumine Injection Sales by Type
8.3 Middle East & Africa Flunixin Meglumine Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Flunixin Meglumine Injection
10.3 Manufacturing Process Analysis of Flunixin Meglumine Injection
10.4 Industry Chain Structure of Flunixin Meglumine Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Flunixin Meglumine Injection Distributors
11.3 Flunixin Meglumine Injection Customer
12 World Forecast Review for Flunixin Meglumine Injection by Geographic Region
12.1 Global Flunixin Meglumine Injection Market Size Forecast by Region
12.1.1 Global Flunixin Meglumine Injection Forecast by Region (2023-2028)
12.1.2 Global Flunixin Meglumine Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Flunixin Meglumine Injection Forecast by Type
12.7 Global Flunixin Meglumine Injection Forecast by Application
13 Key Players Analysis
13.1 Norbrook
13.1.1 Norbrook Company Information
13.1.2 Norbrook Flunixin Meglumine Injection Product Offered
13.1.3 Norbrook Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Norbrook Main Business Overview
13.1.5 Norbrook Latest Developments
13.2 Zoteis
13.2.1 Zoteis Company Information
13.2.2 Zoteis Flunixin Meglumine Injection Product Offered
13.2.3 Zoteis Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zoteis Main Business Overview
13.2.5 Zoteis Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Flunixin Meglumine Injection Product Offered
13.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 Virbac Animal Health India Private Limited
13.4.1 Virbac Animal Health India Private Limited Company Information
13.4.2 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Offered
13.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Virbac Animal Health India Private Limited Main Business Overview
13.4.5 Virbac Animal Health India Private Limited Latest Developments
13.5 MSD Animal Health
13.5.1 MSD Animal Health Company Information
13.5.2 MSD Animal Health Flunixin Meglumine Injection Product Offered
13.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 MSD Animal Health Main Business Overview
13.5.5 MSD Animal Health Latest Developments
13.6 Bengal Remedies Limited
13.6.1 Bengal Remedies Limited Company Information
13.6.2 Bengal Remedies Limited Flunixin Meglumine Injection Product Offered
13.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bengal Remedies Limited Main Business Overview
13.6.5 Bengal Remedies Limited Latest Developments
13.7 Wuhan Huisheng Biological Technology Co., Ltd.
13.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
13.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Offered
13.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Main Business Overview
13.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Latest Developments
13.8 Qilu Animal Health Products Co., Ltd.
13.8.1 Qilu Animal Health Products Co., Ltd. Company Information
13.8.2 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Offered
13.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Qilu Animal Health Products Co., Ltd. Main Business Overview
13.8.5 Qilu Animal Health Products Co., Ltd. Latest Developments
13.9 Baimukang Animal Pharmaceutical Co., Ltd.
13.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information
13.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
13.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Latest Developments
13.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
13.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
13.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Offered
13.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Main Business Overview
13.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Latest Developments
13.11 Hebei New Century Pharmaceutical Co., Ltd.
13.11.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information
13.11.2 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
13.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hebei New Century Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Hebei New Century Pharmaceutical Co., Ltd. Latest Developments
13.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
13.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
13.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
13.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Latest Developments
13.13 Shandong Lukang Pharmaceutical Co., Ltd.
13.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
13.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
13.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Flunixin Meglumine Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Flunixin Meglumine Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10ml/Dose
Table 4. Major Players of 20ml/ Dose
Table 5. Global Flunixin Meglumine Injection Sales by Type (2017-2022) & (K Doses)
Table 6. Global Flunixin Meglumine Injection Sales Market Share by Type (2017-2022)
Table 7. Global Flunixin Meglumine Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Flunixin Meglumine Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Flunixin Meglumine Injection Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global Flunixin Meglumine Injection Sales by Application (2017-2022) & (K Doses)
Table 11. Global Flunixin Meglumine Injection Sales Market Share by Application (2017-2022)
Table 12. Global Flunixin Meglumine Injection Revenue by Application (2017-2022)
Table 13. Global Flunixin Meglumine Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Flunixin Meglumine Injection Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global Flunixin Meglumine Injection Sales by Company (2020-2022) & (K Doses)
Table 16. Global Flunixin Meglumine Injection Sales Market Share by Company (2020-2022)
Table 17. Global Flunixin Meglumine Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Flunixin Meglumine Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Flunixin Meglumine Injection Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers Flunixin Meglumine Injection Producing Area Distribution and Sales Area
Table 21. Players Flunixin Meglumine Injection Products Offered
Table 22. Flunixin Meglumine Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Flunixin Meglumine Injection Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Flunixin Meglumine Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Flunixin Meglumine Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Flunixin Meglumine Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Flunixin Meglumine Injection Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Flunixin Meglumine Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Flunixin Meglumine Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Flunixin Meglumine Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Flunixin Meglumine Injection Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Flunixin Meglumine Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Flunixin Meglumine Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Flunixin Meglumine Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Flunixin Meglumine Injection Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Flunixin Meglumine Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Flunixin Meglumine Injection Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Flunixin Meglumine Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Flunixin Meglumine Injection Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Flunixin Meglumine Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Flunixin Meglumine Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Flunixin Meglumine Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Flunixin Meglumine Injection Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Flunixin Meglumine Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Flunixin Meglumine Injection Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Flunixin Meglumine Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Flunixin Meglumine Injection Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Flunixin Meglumine Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Flunixin Meglumine Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Flunixin Meglumine Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Flunixin Meglumine Injection Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Flunixin Meglumine Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Flunixin Meglumine Injection Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Flunixin Meglumine Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Flunixin Meglumine Injection Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Flunixin Meglumine Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Flunixin Meglumine Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Flunixin Meglumine Injection Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Flunixin Meglumine Injection Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Flunixin Meglumine Injection
Table 66. Key Market Challenges & Risks of Flunixin Meglumine Injection
Table 67. Key Industry Trends of Flunixin Meglumine Injection
Table 68. Flunixin Meglumine Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Flunixin Meglumine Injection Distributors List
Table 71. Flunixin Meglumine Injection Customer List
Table 72. Global Flunixin Meglumine Injection Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Flunixin Meglumine Injection Sales Market Forecast by Region
Table 74. Global Flunixin Meglumine Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Flunixin Meglumine Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Flunixin Meglumine Injection Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Flunixin Meglumine Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Flunixin Meglumine Injection Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Flunixin Meglumine Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Flunixin Meglumine Injection Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Flunixin Meglumine Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Flunixin Meglumine Injection Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Flunixin Meglumine Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Flunixin Meglumine Injection Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Flunixin Meglumine Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Flunixin Meglumine Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Flunixin Meglumine Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Flunixin Meglumine Injection Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Flunixin Meglumine Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Flunixin Meglumine Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Flunixin Meglumine Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Norbrook Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Norbrook Flunixin Meglumine Injection Product Offered
Table 94. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. Norbrook Main Business
Table 96. Norbrook Latest Developments
Table 97. Zoteis Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Zoteis Flunixin Meglumine Injection Product Offered
Table 99. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. Zoteis Main Business
Table 101. Zoteis Latest Developments
Table 102. Merck Animal Health Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Animal Health Flunixin Meglumine Injection Product Offered
Table 104. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. Merck Animal Health Main Business
Table 106. Merck Animal Health Latest Developments
Table 107. Virbac Animal Health India Private Limited Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Offered
Table 109. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 110. Virbac Animal Health India Private Limited Main Business
Table 111. Virbac Animal Health India Private Limited Latest Developments
Table 112. MSD Animal Health Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. MSD Animal Health Flunixin Meglumine Injection Product Offered
Table 114. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 115. MSD Animal Health Main Business
Table 116. MSD Animal Health Latest Developments
Table 117. Bengal Remedies Limited Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Bengal Remedies Limited Flunixin Meglumine Injection Product Offered
Table 119. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 120. Bengal Remedies Limited Main Business
Table 121. Bengal Remedies Limited Latest Developments
Table 122. Wuhan Huisheng Biological Technology Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 124. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 125. Wuhan Huisheng Biological Technology Co., Ltd. Main Business
Table 126. Wuhan Huisheng Biological Technology Co., Ltd. Latest Developments
Table 127. Qilu Animal Health Products Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 129. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 130. Qilu Animal Health Products Co., Ltd. Main Business
Table 131. Qilu Animal Health Products Co., Ltd. Latest Developments
Table 132. Baimukang Animal Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 134. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 135. Baimukang Animal Pharmaceutical Co., Ltd. Main Business
Table 136. Baimukang Animal Pharmaceutical Co., Ltd. Latest Developments
Table 137. Shandong Zhongmu Veterinary Medicine Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 139. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 140. Shandong Zhongmu Veterinary Medicine Co., Ltd. Main Business
Table 141. Shandong Zhongmu Veterinary Medicine Co., Ltd. Latest Developments
Table 142. Hebei New Century Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 144. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 145. Hebei New Century Pharmaceutical Co., Ltd. Main Business
Table 146. Hebei New Century Pharmaceutical Co., Ltd. Latest Developments
Table 147. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 149. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 150. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Main Business
Table 151. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Latest Developments
Table 152. Shandong Lukang Pharmaceutical Co., Ltd. Basic Information, Flunixin Meglumine Injection Manufacturing Base, Sales Area and Its Competitors
Table 153. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Offered
Table 154. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 155. Shandong Lukang Pharmaceutical Co., Ltd. Main Business
Table 156. Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Flunixin Meglumine Injection
Figure 2. Flunixin Meglumine Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Flunixin Meglumine Injection Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Flunixin Meglumine Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Flunixin Meglumine Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10ml/Dose
Figure 10. Product Picture of 20ml/ Dose
Figure 11. Global Flunixin Meglumine Injection Sales Market Share by Type in 2021
Figure 12. Global Flunixin Meglumine Injection Revenue Market Share by Type (2017-2022)
Figure 13. Flunixin Meglumine Injection Consumed in Animal muscle pain
Figure 14. Global Flunixin Meglumine Injection Market: Animal muscle pain (2017-2022) & (K Doses)
Figure 15. Flunixin Meglumine Injection Consumed in Animal febrile disease
Figure 16. Global Flunixin Meglumine Injection Market: Animal febrile disease (2017-2022) & (K Doses)
Figure 17. Flunixin Meglumine Injection Consumed in Others
Figure 18. Global Flunixin Meglumine Injection Market: Others (2017-2022) & (K Doses)
Figure 19. Global Flunixin Meglumine Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Flunixin Meglumine Injection Revenue Market Share by Application in 2021
Figure 21. Flunixin Meglumine Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Flunixin Meglumine Injection Revenue Market Share by Company in 2021
Figure 23. Global Flunixin Meglumine Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Flunixin Meglumine Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Flunixin Meglumine Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Flunixin Meglumine Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Flunixin Meglumine Injection Sales 2017-2022 (K Doses)
Figure 28. Americas Flunixin Meglumine Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Flunixin Meglumine Injection Sales 2017-2022 (K Doses)
Figure 30. APAC Flunixin Meglumine Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Flunixin Meglumine Injection Sales 2017-2022 (K Doses)
Figure 32. Europe Flunixin Meglumine Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Flunixin Meglumine Injection Sales 2017-2022 (K Doses)
Figure 34. Middle East & Africa Flunixin Meglumine Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Flunixin Meglumine Injection Sales Market Share by Country in 2021
Figure 36. Americas Flunixin Meglumine Injection Revenue Market Share by Country in 2021
Figure 37. United States Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Flunixin Meglumine Injection Sales Market Share by Region in 2021
Figure 42. APAC Flunixin Meglumine Injection Revenue Market Share by Regions in 2021
Figure 43. China Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Flunixin Meglumine Injection Sales Market Share by Country in 2021
Figure 50. Europe Flunixin Meglumine Injection Revenue Market Share by Country in 2021
Figure 51. Germany Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Flunixin Meglumine Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Flunixin Meglumine Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Flunixin Meglumine Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Flunixin Meglumine Injection in 2021
Figure 64. Manufacturing Process Analysis of Flunixin Meglumine Injection
Figure 65. Industry Chain Structure of Flunixin Meglumine Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...